Discover 1,670 paid clinical trials in Atlanta, Georgia. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Atlanta’s leading healthcare centers are recruiting participants for studies focused on developing innovative treatments for conditions such as cancer, depression, high blood pressure, and kidney disease. Whether you’re searching for paid clinical research opportunities as a healthy volunteer or trials for specific conditions, Atlanta provides a wide range of research options to meet your needs.
Filter
2
Filter results
Results: 1,670
Active & Responsive
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
for
Human Immunodeficiency Virus Type 1 (HIV-1) Infection
Location: Decatur GA, Macon GA, Charlotte NC, Greensboro NC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07266831
Phase 2, Phase 3, Recruiting
Active & Responsive
A Clinical Study of Letermovir (MK-8228) in Children and Adolescents Who Receive a Kidney Transplant (KT) (MK-8228-077)
for
Cytomegalovirus Prophylaxis
Location: Atlanta GA, Birmingham AL, Charlotte NC, Durham NC,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 0 - 17
Code: NCT07199465
Phase 1, Recruiting
Active & Responsive
Sirolimus in Combination With Metronomic Chemotherapy in Children With High-Risk Solid Tumors
for
Solid Tumor
Location: Atlanta GA, St Louis MO, Pittsburgh PA, Houston TX
Sponsor: Emory University
Sex: All
Age: 1 - 30
Code: NCT04469530
Phase 2, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia
for
Non-Transfusion-dependent Alpha-Thalassemia,
Location: Atlanta GA, Philadelphia PA, Dallas TX, New York NY,
Sponsor: Agios Pharmaceuticals, Inc.
Sex: All
Age: 1 - 17
Code: NCT07517133
Phase 3, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)
for
Transfusion-dependent Alpha-Thalassemia,
Location: Atlanta GA, Philadelphia PA, Dallas TX, New York NY
Sponsor: Agios Pharmaceuticals, Inc.
Sex: All
Age: 1 - 17
Code: NCT07506863
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
Phase 3, Open-label, Single-dose Study of CSL222 in Adolescent Male Subjects (≥ 12 to < 18 Years of Age) With Severe or Moderately Severe Hemophilia B
for
Hemophilia B
Location: Atlanta GA, Gainesville FL, Memphis TN, Ann Arbor MI,
Sponsor: CSL Behring
Sex: Male
Age: 11 - 17
Code: NCT07080905
Phase 3, Recruiting
Active & Responsive
Tegavivint With Gemcitabine in Patients With Relapsed or Refractory Osteosarcoma
for
Osteosarcoma Recurrent, Osteosarcoma in Children,
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 1 - 30
Code: NCT07144254
Phase 1, Recruiting
Active & Responsive
Testing a Standardized Approach to Surgery and Chemotherapy for Type I Pleuropulmonary Blastoma or the Addition of an Anti-cancer Drug, Topotecan, to the Usual Treatment for Types II and III Pleuropulmonary Blastoma
for
Pleuropulmonary Blastoma
Location: Atlanta GA, Greenville SC, Birmingham AL, Nashville TN,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 21
Code: NCT06647953
Phase 3, Recruiting
Active & Responsive
A/Texas Flu Challenge
for
Influenza
Location: Atlanta GA
Sponsor: Emory University
Sex: All
Age: 18 - 49
Code: NCT06753474
Phase 1, Recruiting
Active & Responsive
Effects of Ublituximab on Motor Functions in Multiple Sclerosis
for
Multiple Sclerosis (MS) - Relapsing-remitting
Location: Atlanta GA
Sponsor: Georgia State University
Sex: All
Age: 18 - 55
Code: NCT06629428
Early Phase 1, Recruiting
Active & Responsive
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
for
Myotonic Dystrophy Type 1 (DM1), DM1, Myotonic Dystrophy,
Location: Atlanta GA, Hillsborough NC, Gainesville FL,
Sponsor: Dyne Therapeutics
Sex: All
Age: 16+
Code: NCT07486934
Phase 3, Recruiting
Active & Responsive
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
Location: Atlanta GA, Snellville GA, Little Rock AR, St Louis MO,
Sponsor: LB Pharmaceuticals Inc.
Sex: All
Age: 18 - 65
Code: NCT07369154
Phase 3, Recruiting
Active & Responsive
NBI-1065845-MDD3025: Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Atlanta GA, Mason OH, Tampa FL, Charlottesville VA,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06911112
Phase 3, Recruiting
Active & Responsive
Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
for
Major Depressive Disorder With Excessive Daytime Sleepiness Symptoms,
Location: Atlanta GA, Norcross GA, Snellville GA, Jacksonville FL,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 18 - 65
Code: NCT07484217
Phase 3, Recruiting
Active & Responsive
Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)
for
Major Depressive Disorder
Location: Atlanta GA, Maitland FL, Tampa FL, Little Rock AR,
Sponsor: Neurocrine Biosciences
Sex: All
Age: 18+
Code: NCT06966401
Phase 3, Recruiting
Active & Responsive
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-3)
for
ADHD
Location: Atlanta GA, Dothan AL, North Charleston SC,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 12 - 17
Code: NCT07717892
Phase 3, Recruiting
Active & Responsive
Forward Treatment of Attention Deficit and Hyperactivity Using Solriamfetol (FOCUS-2)
for
ADHD
Location: Atlanta GA, Dothan AL, North Charleston SC,
Sponsor: Axsome Therapeutics, Inc.
Sex: All
Age: 6 - 11
Code: NCT07717879
Phase 3, Recruiting
Active & Responsive
PF614 Analgesic Activity in Acute Postoperative Pain (PF614-301)
for
Postoperative Pain, Acute
Location: Atlanta GA, Houston TX, Salt Lake City UT
Sponsor: Ensysce Biosciences
Sex: All
Age: 18 - 70+
Code: NCT06602271
Phase 3, Recruiting
Active & Responsive
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis
for
Atopic Dermatitis
Location: Douglasville GA, Nashville TN, Bowling Green KY,